Blog - QualityStocks

WednesdayMar 18, 2026 11:15 am

Earth Science Tech Inc. (ETST) Builds Telehealth, Pharmacy Links in Evolving Digital Care

Patients increasingly prefer access, speed and convenience, but healthcare systems also need better coordination, safer medication workflows and clearer continuity of care. DelveInsights has projected that the global telehealth market will reach $2 trillion by 2034, driven by a digital healthcare transformation. ETST is not approaching telehealth as a standalone app or referral layer but as part of a broader operating structure that includes medication fulfillment capacity and patient-facing services. Telehealth is evolving from a simple video visit into something far more comprehensive: a connected care model that can move a patient from consultation to prescription, fulfillment and follow-up inside…

WednesdayMar 18, 2026 10:49 am

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures Costa Rica Approval for Kinesiology Tape Line

Nutriband (NASDAQ: NTRB) announced that the Costa Rica Ministry of Health has approved its line of kinesiology tapes for import and sale, with exclusive distribution partner Innomedica CCB overseeing and financing the regulatory process. The company plans to ramp up marketing efforts in partnership with Innomedica, targeting both its kinesiology tape products and mosquito repellent patch line following the approval. To view the full press release, visit https://ibn.fm/CJqLZ About Nutriband Inc. We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA(TM) abuse-deterrent technology. AVERSA(TM) technology can be incorporated into any transdermal…

WednesdayMar 18, 2026 10:40 am

QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Featured in NetworkNewsAudio APR on Emerging Gold Producer Opportunity

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) is featured in a NetworkNewsAudio Audio Press Release titled “Record Gold Prices Reshape Opportunities for Emerging Producers,” which highlights how developers with existing infrastructure, defined resources and a credible near-term path to production may stand out as gold prices rise. The piece notes LaFleur progress in Québec Abitibi Gold Belt, where the company has advanced its Swanson Gold Deposit and wholly owned Beacon Gold Mill through economic studies, exploration results, mill restart work and financing, supporting its mine-to-mill strategy aimed at moving from exploration…

WednesdayMar 18, 2026 10:30 am

Beeline Holdings Inc. (NASDAQ: BLNE) Partners with TYTL Corp on Tokenized Fractional Real Estate Model

Beeline Holdings Inc. has partnered with TYTL Corp. to support fractional equity transactions in U.S. residential real estate, and have already finalized 11 fractional equity acquisitions and launched an initial property portfolio. The product is branded at BeelineEquity and can be found on Beeline's website representing a significant revenue opportunity for Beeline - Every $1B in transaction value represents $41M in revenue for Beeline. Tokenization model combines traditional and blockchain infrastructure, as property interests are deed-recorded through standard closings before being tokenized on-chain. Beeline’s digital mortgage, title, and closing infrastructure will facilitate scaling of the fractional equity model, with the…

WednesdayMar 18, 2026 9:45 am

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Identifies Rare Earth Mineralization at Cameron Project, Expands Exploration Targets

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. Canadian mineral exploration company Powermax Minerals has reported soil and rock sampling results indicating rare earth element mineralization at the Cameron REE Project in British Columbia. Soil samples returned Total Rare Earth Oxide (“TREO”) values ranging from 135 ppm to 2,840 ppm, outlining a mineralized corridor more than one kilometre long, with rock sampling returning values up to 741 ppm TREO, supporting the potential presence of REE-bearing bedrock. Results suggest REE mineralization associated with NYF-type pegmatites, a geological setting known to host rare earth…

WednesdayMar 18, 2026 9:20 am

QualityStocksNewsBreaks – Renewal Fuels, Inc. (OTC: RNWF) To Begin Trading As American Fusion Inc. Under AMFN Ticker

Renewal Fuels (OTC: RNWF) will begin trading as American Fusion Inc. under the ticker symbol “AMFN” effective March 19, 2026, following FINRA processing of the company corporate name and symbol change, as reflected on the March 18 FINRA Daily List. The transition follows the company merger with Kepler Fusion Technologies and aligns its public market identity with its strategy to advance the Texatron(TM) aneutronic fusion platform as a scalable, infrastructure-grade energy solution targeting commercial deployment. To view the full press release, visit: https://ibn.fm/nH5HQ About Renewal Fuels, Inc. and American Fusion Renewal Fuels, Inc. (OTC: RNWF) is an advanced energy platform…

WednesdayMar 18, 2026 9:00 am

Soligenix Inc. (NASDAQ: SNGX) Advances Rare Disease Innovation Through Platform Science and Expanding Therapeutic Pipeline

High-quality development platforms and translational research frameworks have become essential tools in rare-disease biotechnology. Soligenix is leveraging its platform science to expand the therapeutic reach of its development programs and explore additional disease indications. The broader emphasis of Soligenix’s platform science approach is to maximize the scientific value of its research infrastructure. Medical progress has transformed the treatment of many common illnesses, yet thousands of rare diseases still lack effective therapies. Companies working at the intersection of biotechnology innovation and rare disease research are increasingly focused on addressing these gaps, including Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing and…

WednesdayMar 18, 2026 9:00 am

QualityStocksNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Reports Breakthrough in Liquid Biopsy With Over 99% Cancer DNA Purity

VolitionRx (NYSE American: VNRX) announced a breakthrough in liquid biopsy technology, achieving over 99% purity in isolating circulating tumor-derived DNA using its Capture-Seq(TM) platform, overcoming a longstanding challenge of distinguishing cancer DNA from healthy cell-free DNA in blood samples. The company reported strong early validation results, including no false positives and successful detection across initial study cohorts, supporting the potential of the technology as a novel biomarker approach. The company said the advancement could support applications in multi-cancer early detection and minimal residual disease monitoring, representing a combined total addressable market of approximately $36 billion. Volition added that it is…

TuesdayMar 17, 2026 12:04 pm

QualityStocksNewsBreaks – Cyngn Inc. (NASDAQ: CYN) Closes $9.65 Million Registered Direct Offering

Cyngn (NASDAQ: CYN) announced the closing of its previously announced registered direct offering, raising approximately $9.65 million in gross proceeds through the sale of 5,000,000 shares of common stock and pre-funded warrants at $1.93 per share, with the majority of the offering purchased by a single institutional investor. The transaction was priced at the market under Nasdaq rules and closed on March 17, 2026, with proceeds expected to support general corporate purposes and working capital. Aegis Capital Corp. acted as exclusive placement agent. To view the full press release, visit https://ibn.fm/I9nCc About Cyngn Cyngn develops and deploys autonomous vehicle technology for industrial organizations like manufacturers and logistics companies. The Company addresses significant challenges…

TuesdayMar 17, 2026 11:40 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Feedback On Bioequivalence For Ketamine Product

NRx Pharmaceuticals (NASDAQ: NRXP) announced it received a letter from the FDA’s Bioequivalence Program stating no bioequivalence deficiencies were identified at this time in its Abbreviated New Drug Application, with a preliminary determination ahead of anticipated approval in Summer 2026. The company highlighted its preservative-free ketamine formulation, which excludes benzethonium chloride, as a potential advancement in safety and stability, while continuing to pursue regulatory pathways for broader therapeutic use. To view the full press release, visit https://ibn.fm/AJIVD About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals, Inc. (www.nrxpharma.com), is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic…

Site Search

Company Search